The History of Stem Cell Medical Advancement

Major Advances in Stem Cell Treatment

1868 – 2026

A Comprehensive Timeline

Stem cell therapy has become a beacon of hope, offering treatments for conditions once deemed untreatable. These remarkable breakthroughs are not the product of recent discoveries but the result of over a century of scientific advancement. This timeline maps the incredible journey of stem cell development, charting its evolution from theoretical beginnings to life-changing medical applications.

Since the term “stem cell” first emerged in 1868, each milestone reflects a deeper understanding of cellular biology — reshaping the possibilities for treating conditions from leukemia to neurodegenerative disorders, and opening doors to the regenerative therapies and personalized medicine that redefine how we approach healing.

1868

First Use of the Term "Stem Cell"

Ernst Haeckel, a German biologist, introduces the term "Stammzelle" (stem cell) in his work on evolution to describe the ancestor unicellular organism from which all multicellular organisms evolved.
source
1908

Concept of Hematopoietic Stem Cells Proposed

Russian histologist Alexander Maksimov proposes the existence of hematopoietic stem cells at the Congress of Hematologic Society in Berlin, laying the foundation for stem cell research.
source
1956

First Successful Bone Marrow Transplant

Dr. E. Donnall Thomas performs the first successful bone marrow transplant between identical twins to treat leukemia.
source
1961

Discovery of Hematopoietic Stem Cells

Event: Ernest McCulloch and James Till demonstrate the existence of self-renewing cells in bone marrow, pioneering the concept of stem cells.
source
1963

Stem Cells Demonstrated to Self-Renew

McCulloch and Till show that stem cells can self-renew and differentiate into multiple cell types
source
1968

First Successful Allogeneic Bone Marrow Transplant

Dr. Robert A. Good performs the first successful bone marrow transplant between siblings who are not identical twins, treating severe combined immunodeficiency disease (SCID)
source
1970

Identification of Mesenchymal Stem Cells

Alexander Friedenstein identifies stromal cells in bone marrow capable of forming bone, cartilage, and other tissues.
source
1974

Discovery of Hematopoietic Stem Cells in Cord Blood

Scientists discover that umbilical cord blood contains hematopoietic stem cells, paving the way for cord blood transplantation.
source
1981

Isolation of Embryonic Stem Cells from Mice

Dr. Martin Evans and Matthew Kaufman successfully isolate embryonic stem cells from mouse embryos, demonstrating pluripotency.
source
1988

First Successful Umbilical Cord Blood Transplant

Dr. Eliane Gluckman performs the first successful cord blood transplant on a child with Fanconi anemia.
source
1989

Discovery of Neural Stem Cells in Adult Brain

Researchers identify neural stem cells in the adult mammalian brain, challenging the belief that neurogenesis only occurs during development.
source
1992

First Isolation of Neural Stem Cells

Isolation and characterization of neural stem cells provide insights into brain development and potential therapies.
source
1995

Discovery of Cancer Stem Cells in Leukemia

John Dick identifies cancer stem cells in human leukemia, suggesting that cancer may arise from stem cells.
source
1998

Derivation of Human Embryonic Stem Cells

Dr. James Thomson and his team derive the first human embryonic stem cell lines, capable of developing into any cell type.
source
1999

Stem Cell Therapy in Animals for Spinal Cord Injury

Researchers demonstrate that transplanted stem cells can aid recovery in rats with spinal cord injuries.
source
2001

First Clinical Trial Using Stem Cells for Heart Disease

Dr. Bodo-Eckehard Strauer conducts a clinical trial using autologous bone marrow stem cells to treat myocardial infarction patients.
source
2004

International Stem Cell Forum Established

Major funding agencies worldwide create the International Stem Cell Forum (ISCF) to promote global collaboration in stem cell research.
source
2005

Stem Cells Restore Vision

Transplantation of limbal stem cells restores vision in patients with corneal blindness.
source
2006

Introduction of Induced Pluripotent Stem Cells (iPSCs)

Dr. Shinya Yamanaka reprograms adult mouse fibroblasts into pluripotent stem cells, introducing iPSC technology.
source
2007

Generation of Human iPSCs

iPSCs are generated from adult human fibroblasts, offering patient-specific pluripotent cells.
source
2007

Stem Cells Used to Grow New Skin for Burn Patients

Cultured epithelial autografts are used to generate new skin for severe burn victims.
source
2008

Creation of Disease-Specific Stem Cell Lines

Patient-specific iPSC lines are created to study diseases like amyotrophic lateral sclerosis (ALS).
source
2009

Expansion of Federal Funding for Stem Cell Research

U.S. President Barack Obama lifts restrictions on federal funding for embryonic stem cell research.
source
2010

Stem Cell Therapy for Spinal Cord Injury

Geron Corporation initiates the first FDA-approved clinical trial using embryonic stem cells to treat acute spinal cord injury.
source
2011

Stem Cell Therapy Used to Treat Blindness in Human Trials

Patients receive retinal pigment epithelium derived from embryonic stem cells, showing improved vision.
source
2012

Nobel Prize Awarded for Stem Cell Research

Shinya Yamanaka and Sir John Gurdon receive the Nobel Prize in Physiology or Medicine for discovering that mature cells can be reprogrammed to become pluripotent.
source
2012

First Clinical Use of iPSC-Derived Cells

Japan approves a clinical study using iPSC-derived retinal pigment epithelium cells to treat age-related macular degeneration.
source
2013

Human Embryonic Stem Cells Created by Cloning

Scientists successfully derive human embryonic stem cells through somatic cell nuclear transfer.
source
2013

Mini-Organs Grown from Stem Cells

Organoids resembling human brains, kidneys, and intestines are grown from stem cells for disease modeling.
source
2014

Stem Cell Therapy for Age-Related Macular Degeneration

Preliminary results show improved vision in patients receiving embryonic stem cell-derived retinal cells.
source
2014

Use of Stem Cells to Model Diseases In Vitro

iPSC-derived cells are used to model diseases like Alzheimer’s and Parkinson’s in the lab.
source
2014

Cerebral Palsy

Autologous cord blood stem cells are shown to enhance mobility and reduce spasticity in children with cerebral palsy.
source
2014

Advances in Stem Cell Therapy for Diabetes

Scientists develop a method to create insulin-producing beta cells from stem cells, offering potential new treatments for diabetes patients.
source
2015

First Clinical Trial of Stem Cell Therapy for Autism

Duke University initiates a trial using autologous umbilical cord blood stem cells to treat autism, showing promising improvements in behavior and communication.
source
2016

Stem Cells Improve Recovery in Stroke Patients

Clinical trial demonstrates that modified bone marrow-derived stem cells improve motor function in stroke patients.
source
2016

Ataxia

Initial clinical trials demonstrate that stem cells improve motor coordination in ataxia patients.
source
2016

Gene Editing in Stem Cells Using CRISPR

CRISPR technology is used to correct genetic mutations in stem cells, advancing personalized medicine.
source
2017

Stem Cell Gene Therapy for Sickle Cell Disease

A teenage boy with sickle cell disease is effectively cured using gene-modified autologous stem cells.
source
2017

Stem Cell Therapy Used to Treat Epidermolysis Bullosa

Gene-corrected epidermal stem cells are used to regenerate skin in a child suffering from a severe skin disorder.
source
2018

Successful Stem Cell Transplant for HIV Patient

The “London patient” goes into HIV remission after receiving a stem cell transplant from a donor with the CCR5-delta 32 mutation.
source
2019

Creation of Functional Mini-Brains from Stem Cells

Advanced cerebral organoids display brain-like electrical activity, aiding neurological research.
source
2019

Stem Cell Therapy for Multiple Sclerosis

Autologous hematopoietic stem cell transplantation (AHSCT) shows significant benefits in patients with relapsing-remitting MS.
source
2019

Muscular Dystrophy

Gene-corrected stem cells regenerate muscle tissue in early studies on muscular dystrophy.
source
2019

Stem Cell Therapy Shows Promise in Treating Osteoarthritis

Mesenchymal stem cells are used in clinical trials to regenerate cartilage and reduce pain in osteoarthritis patients.
source
2020

Stem Cell Treatment for Severe COVID-19

Mesenchymal stem cells are used in trials to treat severe COVID-19 pneumonia, showing potential in reducing inflammation.
source
2020

Advances in Stem Cell Therapy for ALS

Stem cell therapy shows promise in slowing the progression of amyotrophic lateral sclerosis (ALS).
source
2021

Advancements in Stem Cell Therapy for Type 1 Diabetes

Vertex Pharmaceuticals announces that a statement consistent with the 2021 VX-880 update after receiving stem cell-derived islet cells.
source
2021

Stem Cell Therapy Used for Heart Regeneration

Trials show that stem cells can improve heart function after myocardial infarction by regenerating damaged tissue.
source
2021

Spinal Muscular Atrophy (SMA)

An open-label phase 1 clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type 1 patients
source
2022

Breakthrough in Hair Follicle Regeneration from Stem Cells

Scientists generate hair follicles from stem cells, offering potential treatments for hair loss.
source
2022

First Human Trial Using CRISPR-Edited Stem Cells

CRISPR-edited stem cells are used to treat patients with genetic blood disorders, showing positive results.
source
2022

Stem Cells Used to Repair Damaged Lungs

Stem cell therapy shows potential in repairing lung tissue damaged by diseases like COPD and pulmonary fibrosis.
source
2022

Optic Nerve Atrophy (ONA)

Evaluating the impact of mesenchymal stem cell therapy on visual acuity and retinal nerve fiber layer thickness in optic neuropathy patients: a comprehensive systematic review and meta-analysis.
source
2023

Advances in Stem Cell Therapies for Parkinson's Disease

Stem cells are used to replace damaged neurons in Parkinson’s patients, showing improvements in motor function.
source
2023

Stem Cell Therapies for Autism Show Promising Results

Clinical trials report improvements in social interaction and communication in children with autism after stem cell therapy, offering hope for new treatments.
source
2024

Stem Cell Breakthrough Reverses Type 1 Diabetes

Significant advancement in stem cell therapy was the successful reversal of type 1 diabetes in a patient through stem cell treatment.
source
2024

Optic Nerve Hypoplasia (ONH)

Early trials using mesenchymal stem cells report potential improvements in visual function.
source
2024

Spina Bifida

In utero stem cell therapies improve outcomes for spina bifida patients by reducing neural damage.
source
2024

FDA Approval for Pediatric Graft vs. Host Disease Treatment

Ryoncil (remestemcel-L-rknd) receives FDA approval for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older, becoming the first FDA-approved mesenchymal stromal cell (MSC) therapy.
source
2025

First iPSC-Based Therapy Enters a U.S. Phase 3 Clinical Trial (IVF / Egg Maturation)

Gameto receives FDA IND clearance for Fertilo, an iPSC-derived ovarian support cell approach designed to support egg maturation with a reduced hormone-injection burden compared with conventional IVF stimulation protocols.
source
2025

Breakthrough in Cell Therapy for Drug-Resistant Epilepsy

Neurona Therapeutics reports new long-term clinical data from ongoing NRTX-1001 trials in adults with drug-resistant focal epilepsy, including robust seizure reduction in treated participants.
source
2025

CAR T-Cell Therapy for Lupus Using iPSC-Derived Cells

Fate Therapeutics reports updated Phase 1 clinical data for FT819, an off-the-shelf, iPSC-derived CAR T-cell therapy being evaluated for systemic lupus erythematosus (SLE), with treated participants showing meaningful decreases in disease activity.
source
2025

Autologous iPSC Therapy for Parkinson’s Advances

Aspen Neuroscience reports completion of dose escalation and the first two cohorts in the ASPIRO Phase 1/2a trial of ANPD001, an autologous (patient-derived) iPSC-based dopaminergic neuronal precursor cell therapy for Parkinson’s disease.
source
2025

Global Milestone: 116 Regulatory-Approved hPSC Trials and 1,200+ Patients Dosed

A 2025 Cell Stem Cell review reports that, as of December 2024, 83 human pluripotent stem cell (hPSC) products were being evaluated across 116 regulatory-approved clinical trials worldwide, with more than 1,200 patients dosed and no generalizable safety concerns identified.
source
2025

FDA Clears Multiple iPSC Trials for Major CNS Diseases

XellSmart announces FDA IND clearances enabling Phase I clinical trials of allogeneic iPSC-derived cell therapies targeting Parkinson’s disease, ALS, and spinal cord injury.
source
2026

Autologous iPSC Parkinson’s Program Expands Clinical Progress

Aspen Neuroscience reports completion of Cohort Three dosing in the ASPIRO Phase 1/2a trial of ANPD001 and an expansion of GMP manufacturing capabilities to support later-stage clinical development.
source